{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T15:38:12Z","timestamp":1773502692641,"version":"3.50.1"},"update-to":[{"DOI":"10.1371\/journal.pcbi.1008519","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000}}],"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2020,12,23]],"date-time":"2020-12-23T00:00:00Z","timestamp":1608681600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006034","name":"University of Southern California","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006034","id-type":"DOI","asserted-by":"publisher"}]},{"name":"USC Center for Computational Modeling of Cancer"}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"abstract":"<jats:p>Within the tumor microenvironment, macrophages exist in an immunosuppressive state, preventing T cells from eliminating the tumor. Due to this, research is focusing on immunotherapies that specifically target macrophages in order to reduce their immunosuppressive capabilities and promote T cell function. In this study, we develop an agent-based model consisting of the interactions between macrophages, T cells, and tumor cells to determine how the immune response changes due to three macrophage-based immunotherapeutic strategies: macrophage depletion, recruitment inhibition, and macrophage reeducation. We find that reeducation, which converts the macrophages into an immune-promoting phenotype, is the most effective strategy and that the macrophage recruitment rate and tumor proliferation rate (tumor-specific properties) have large impacts on therapy efficacy. We also employ a novel method of using a neural network to reduce the computational complexity of an intracellular signaling mechanistic model.<\/jats:p>","DOI":"10.1371\/journal.pcbi.1008519","type":"journal-article","created":{"date-parts":[[2020,12,23]],"date-time":"2020-12-23T14:52:38Z","timestamp":1608735158000},"page":"e1008519","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":68,"title":["Multi-scale modeling of macrophage\u2014T cell interactions within the tumor microenvironment"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1398-2846","authenticated-orcid":true,"given":"Colin G.","family":"Cess","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6901-3692","authenticated-orcid":true,"given":"Stacey D.","family":"Finley","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2020,12,23]]},"reference":[{"issue":"3","key":"pcbi.1008519.ref001","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","article-title":"Accessories to the crime: functions of cells recruited to the tumor microenvironment","volume":"21","author":"D Hanahan","year":"2012","journal-title":"Cancer Cell"},{"issue":"45","key":"pcbi.1008519.ref002","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.1038\/onc.2008.271","article-title":"The tumor microenvironment and its role in promoting tumor growth","volume":"27","author":"T Whiteside","year":"2008","journal-title":"Oncogene"},{"key":"pcbi.1008519.ref003","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/B978-012372551-6\/50066-3","volume-title":"Cancer Immunotherapy","author":"R Kim","year":"2007"},{"issue":"Suppl 2","key":"pcbi.1008519.ref004","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.3747\/co.27.5223","article-title":"A review of cancer immunotherapy: from the past, to the present, to the future","volume":"27","author":"K Esfahani","year":"2020","journal-title":"Curr Oncol"},{"issue":"12","key":"pcbi.1008519.ref005","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3390\/cancers8120106","article-title":"Advances in cancer immunotherapy in solid tumors","volume":"8","author":"S Menon","year":"2016","journal-title":"Cancers"},{"key":"pcbi.1008519.ref006","first-page":"1","article-title":"Next-generation immuno-oncology agents: current momentum shifts in cancer immunotherapy","volume":"13","author":"C Pan","year":"2020","journal-title":"J Hematol OncolJ Hematol Oncol"},{"issue":"5","key":"pcbi.1008519.ref007","doi-asserted-by":"crossref","first-page":"e373","DOI":"10.3747\/co.25.3840","article-title":"Current landscape of immunotherapy in the treatment of solid tumours, with future opportunities and challenges","volume":"25","author":"N Nixon","year":"2018","journal-title":"Curr Oncol"},{"issue":"1","key":"pcbi.1008519.ref008","first-page":"1","article-title":"Lessons learned from the blockade of immune checkpoints in cancer immunotherapy","volume":"11","author":"X Li","year":"2018","journal-title":"J Hematol OncolJ Hematol Oncol"},{"key":"pcbi.1008519.ref009","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fcell.2018.00038","article-title":"Targeting tumor-associated macrophages as a potential strategy to enhance the response to immune checkpoint inhibitors","volume":"6","author":"L Cassetta","year":"2018","journal-title":"Front Cell Dev Biol"},{"issue":"3","key":"pcbi.1008519.ref010","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.3390\/cancers6031670","article-title":"Tumor-associated macrophages as major players in the tumor microenvironment.","volume":"6","author":"T Chanmee","year":"2014","journal-title":"Cancers"},{"issue":"3","key":"pcbi.1008519.ref011","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2217\/imt-2016-0135","article-title":"Tumor-associated macrophages: implications in cancer immunotherapy","volume":"9","author":"AJ Petty","year":"2017","journal-title":"Immunotherapy"},{"issue":"2","key":"pcbi.1008519.ref012","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.immuni.2014.01.006","article-title":"Transcriptome-based network analysis reveals a spectrum model of human macrophage activation","volume":"40","author":"J Xue","year":"2014","journal-title":"Immunity"},{"issue":"1","key":"pcbi.1008519.ref013","first-page":"1","article-title":"Tumor associated macrophage: a review on the phenotypes, traits and functions","volume":"7","author":"S Ramanathan","year":"2014","journal-title":"Iran J Cancer Prev"},{"issue":"1","key":"pcbi.1008519.ref014","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","article-title":"Tumor-associated macrophages: from mechanisms to therapy","volume":"41","author":"R Noy","year":"2014","journal-title":"Immunity"},{"issue":"5","key":"pcbi.1008519.ref015","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.molmed.2018.03.006","article-title":"Macrophages: the road less traveled, changing anticancer therapy","volume":"24","author":"JL Guerriero","year":"2018","journal-title":"Trends Mol Med"},{"issue":"1","key":"pcbi.1008519.ref016","first-page":"1","article-title":"Harnessing tumor-associated macrophages as aids for cancer immunotherapy","volume":"18","author":"X Li","year":"2019","journal-title":"Mol Cancer"},{"issue":"8","key":"pcbi.1008519.ref017","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1084\/jem.20092454","article-title":"Tumor masses support naive T cell infiltration, activation, and differentiation into effectors","volume":"207","author":"ED Thompson","year":"2010","journal-title":"J Exp Med"},{"key":"pcbi.1008519.ref018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.csbj.2018.11.004","article-title":"Fates of CD8+ T cells in tumor microenvironment","volume":"17","author":"NR Maimela","year":"2019","journal-title":"Comput Struct Biotechnol J"},{"issue":"6","key":"pcbi.1008519.ref019","doi-asserted-by":"crossref","first-page":"8509","DOI":"10.1002\/jcp.27782","article-title":"CD8+ cytotoxic T lymphocytes in cancer immunotherapy: A review","volume":"234","author":"B Farhood","year":"2019","journal-title":"J Cell Physiol"},{"issue":"1","key":"pcbi.1008519.ref020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/2051-1426-2-3","article-title":"Mechanism of tumor rejection with doublets of CTLA-4, PD-1\/PD-L1, or IDO blockade involves restored IL-2 production and proliferation of CD8+ T cells directly within the tumor microenvironment","volume":"2","author":"S Spranger","year":"2014","journal-title":"J Immunother Cancer"},{"issue":"8","key":"pcbi.1008519.ref021","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"EJ Wherry","year":"2015","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"pcbi.1008519.ref022","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1158\/0008-5472.CAN-11-3687","article-title":"T-regulatory cells: key players in tumor immune escape and angiogenesis","volume":"72","author":"A Facciabene","year":"2012","journal-title":"Cancer Res"},{"issue":"8","key":"pcbi.1008519.ref023","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/s41591-019-0522-3","article-title":"Clonal replacement of tumor-specific T cells following PD-1 blockade","volume":"25","author":"KE Yost","year":"2019","journal-title":"Nat Med"},{"issue":"4","key":"pcbi.1008519.ref024","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00428-018-2484-0","article-title":"Adoptive cellular therapies: the current landscape","volume":"474","author":"MW Rohaan","year":"2019","journal-title":"Virchows Arch"},{"issue":"4","key":"pcbi.1008519.ref025","doi-asserted-by":"crossref","first-page":"e1484","DOI":"10.1002\/wsbm.1484","article-title":"Modeling immune cell behavior across scales in cancer","volume":"12","author":"SZ Makaryan","year":"2020","journal-title":"Wiley Interdiscip Rev Syst Biol Med"},{"issue":"134","key":"pcbi.1008519.ref026","doi-asserted-by":"crossref","first-page":"20170320","DOI":"10.1098\/rsif.2017.0320","article-title":"A computational multiscale agent-based model for simulating spatio-temporal tumour immune response to PD1 and PDL1 inhibition","volume":"14","author":"C Gong","year":"2017","journal-title":"J R Soc Interface"},{"issue":"22","key":"pcbi.1008519.ref027","doi-asserted-by":"crossref","first-page":"6442","DOI":"10.1158\/0008-5472.CAN-17-2006","article-title":"In silico modeling of immunotherapy and stroma-targeting therapies in human colorectal cancer","volume":"77","author":"JN Kather","year":"2017","journal-title":"Cancer Res"},{"issue":"10","key":"pcbi.1008519.ref028","doi-asserted-by":"crossref","first-page":"e1002742","DOI":"10.1371\/journal.pcbi.1002742","article-title":"Modeling protective anti-tumor immunity via preventative cancer vaccines using a hybrid agent-based and delay differential equation approach","volume":"8","author":"PS Kim","year":"2012","journal-title":"PLoS Comput Biol"},{"issue":"4","key":"pcbi.1008519.ref029","doi-asserted-by":"crossref","first-page":"e1004181","DOI":"10.1371\/journal.pcbi.1004181","article-title":"Spatial and functional heterogeneities shape collective behavior of tumor-immune networks","volume":"11","author":"DK Wells","year":"2015","journal-title":"PLoS Comput Biol"},{"issue":"1","key":"pcbi.1008519.ref030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40425-017-0313-7","article-title":"Mathematical modeling of tumor-associated macrophage interactions with the cancer microenvironment","volume":"6","author":"G Mahlbacher","year":"2018","journal-title":"J Immunother Cancer"},{"key":"pcbi.1008519.ref031","first-page":"1","article-title":"Acidity promotes tumour progression by altering macrophage phenotype in prostate cancer","author":"A El-Kenawi","year":"2019","journal-title":"Br J Cancer"},{"issue":"1","key":"pcbi.1008519.ref032","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1039\/C5IB00201J","article-title":"3-D individual cell based computational modeling of tumor cell\u2013macrophage paracrine signaling mediated by EGF and CSF-1 gradients","volume":"8","author":"H Knutsdottir","year":"2016","journal-title":"Integr Biol"},{"key":"pcbi.1008519.ref033","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jtbi.2014.04.031","article-title":"Mathematical model of macrophage-facilitated breast cancer cells invasion","volume":"357","author":"H Kn\u00fatsd\u00f3ttir","year":"2014","journal-title":"J Theor Biol"},{"key":"pcbi.1008519.ref034","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jtbi.2018.05.003","article-title":"Modeling triple-negative breast cancer heterogeneity: Effects of stromal macrophages, fibroblasts and tumor vasculature","volume":"452","author":"K-A Norton","year":"2018","journal-title":"J Theor Biol"},{"issue":"1","key":"pcbi.1008519.ref035","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1742-4682-4-39","article-title":"The Basic Immune Simulator: an agent-based model to study the interactions between innate and adaptive immunity","volume":"4","author":"VA Folcik","year":"2007","journal-title":"Theor Biol Med Model"},{"key":"pcbi.1008519.ref036","article-title":"Evaluating the polarization of tumor-associated macrophages into M1 and M2 phenotypes in human cancer tissue: technicalities and challenges in routine clinical practice","volume":"9","author":"SD Jayasingam","year":"2019","journal-title":"Front Oncol"},{"issue":"5","key":"pcbi.1008519.ref037","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S1470-2045(16)00078-4","article-title":"Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial","volume":"17","author":"TM Nywening","year":"2016","journal-title":"Lancet Oncol"},{"issue":"2","key":"pcbi.1008519.ref038","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ccr.2013.01.008","article-title":"Role of macrophage targeting in the antitumor activity of trabectedin","volume":"23","author":"G Germano","year":"2013","journal-title":"Cancer Cell"},{"issue":"8","key":"pcbi.1008519.ref039","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1158\/2159-8290.CD-15-1346","article-title":"Macrophage PI3K\u03b3 drives pancreatic ductal adenocarcinoma progression","volume":"6","author":"MM Kaneda","year":"2016","journal-title":"Cancer Discov"},{"key":"pcbi.1008519.ref040","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2018.01.002","article-title":"Size-based separation methods of circulating tumor cells","volume":"125","author":"S-J Hao","year":"2018","journal-title":"Adv Drug Deliv Rev"},{"issue":"11","key":"pcbi.1008519.ref041","doi-asserted-by":"crossref","first-page":"e1007468","DOI":"10.1371\/journal.pcbi.1007468","article-title":"A mechanistic integrative computational model of macrophage polarization: Implications in human pathophysiology","volume":"15","author":"C Zhao","year":"2019","journal-title":"PLoS Comput Biol"},{"issue":"6","key":"pcbi.1008519.ref042","doi-asserted-by":"crossref","first-page":"e2836","DOI":"10.1038\/cddis.2017.67","article-title":"Interferon-\u03b3 derived from cytotoxic lymphocytes directly enhances their motility and cytotoxicity","volume":"8","author":"P Bhat","year":"2017","journal-title":"Cell Death Dis"},{"key":"pcbi.1008519.ref043","first-page":"155","volume-title":"Seminars in cancer biology","author":"A Mantovani","year":"2004"},{"issue":"10","key":"pcbi.1008519.ref044","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/ni.1937","article-title":"Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm","volume":"11","author":"SK Biswas","year":"2010","journal-title":"Nat Immunol"},{"key":"pcbi.1008519.ref045","doi-asserted-by":"crossref","first-page":"110125","DOI":"10.1016\/j.jtbi.2019.110125","article-title":"Data-driven analysis of a mechanistic model of CAR T cell signaling predicts effects of cell-to-cell heterogeneity","volume":"489","author":"CG Cess","year":"2020","journal-title":"J Theor Biol"},{"key":"pcbi.1008519.ref046","article-title":"TensorFlow: Large-scale machine learning on heterogeneous systems","author":"M Abadi","year":"2015"},{"key":"pcbi.1008519.ref047","first-page":"73","volume-title":"International Review of Cell and Molecular Biology","author":"JL Guerriero","year":"2019"},{"issue":"3","key":"pcbi.1008519.ref048","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/imm.12647","article-title":"M2 polarization of murine peritoneal macrophages induces regulatory cytokine production and suppresses T-cell proliferation","volume":"149","author":"S Oishi","year":"2016","journal-title":"Immunology"},{"issue":"6","key":"pcbi.1008519.ref049","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/s41577-019-0127-6","article-title":"Macrophages as regulators of tumour immunity and immunotherapy","volume":"19","author":"DG DeNardo","year":"2019","journal-title":"Nat Rev Immunol"}],"updated-by":[{"DOI":"10.1371\/journal.pcbi.1008519","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000}}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1008519","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,18]],"date-time":"2021-04-18T01:37:54Z","timestamp":1618709874000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1008519"}},"subtitle":[],"editor":[{"given":"Kathryn","family":"Miller-Jensen","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2020,12,23]]},"references-count":49,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,12,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1008519","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.08.03.235333","asserted-by":"object"}]},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,23]]}}}